Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
10.12 | 69.4 | -85.42% | 0 | 0% |
| P/S |
|
0.86 | 6.51 | -86.78% |
|
|
| P/BV |
|
0.46 | 3.96 | -88.37% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
23.33 | 11.85 | 96.9% |
|
|
| Ev/S |
|
3.1 | 5.98 | -48.06% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0332 | 0.0396 | -16.15% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
5/10
|
16.18 | 20.39 | -20.63% | 16.18 | 0% |
| ROE |
|
4.5 | 11.95 | -62.33% |
|
|
| ROA |
|
2.47 | 5.4 | -54.27% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
8.53 | 16.23 | -47.45% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
5.96 | 14.63 | -59.24% | 5.96 | 0% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
11.31 | 3.6 | 214.23% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
6.73/10
|
2.69 | 1.83 | 46.76% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.44 | -100% | ||
| DSI |
|
1 | 0.9113 | 9.73% |
|
|
| Average dividend growth |
|
0 | 10.4 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.14 | -100% |
|
|
| Average percentage for payments |
|
0 | 44.8 | -100% |
|
|
| Difference from average difference in sector |
|
0.857 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
0 | 61.43 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
0 | 158.62 | -100% | ||
| Growth impulse Net Income in 5 years |
|
0 | 66.93 | -100% | ||
| Growth impulse FCF in 5 years |
|
0 | 248.41 | -100% | ||
| Growth impulse EPS in 5 years |
|
0 | 73.29 | -100% |
IP Score
4.56/10
